These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 34761111)
1. The influence of MTHFR genetic polymorphisms on methotrexate therapy in pediatric acute lymphoblastic leukemia. Shen Y; Wang Z; Zhou F; Jin R Open Life Sci; 2021; 16(1):1203-1212. PubMed ID: 34761111 [TBL] [Abstract][Full Text] [Related]
2. Involvement of the Guo Q; Sun JL; Li R; Li X Int J Gen Med; 2024; 17():1221-1231. PubMed ID: 38559593 [TBL] [Abstract][Full Text] [Related]
3. C677T and A1298C polymorphisms of the methylenetetrahydrofolate reductase gene: effect on methotrexate-related toxicity in adult acute lymphoblastic leukaemia. Eissa DS; Ahmed TM Blood Coagul Fibrinolysis; 2013 Mar; 24(2):181-8. PubMed ID: 23183238 [TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetic Variants in MTHFR Gene are Significant Predictors of Methotrexate Toxicities in Bangladeshi Patients With Acute Lymphoblastic Leukemia. Zahra FT; Nahid NA; Islam MR; Al-Mamun MMA; Apu MNH; Nahar Z; Kabir AL; Biswas SK; Ahmed MU; Islam MS; Hasnat A Clin Lymphoma Myeloma Leuk; 2020 Feb; 20(2):e58-e65. PubMed ID: 31884153 [TBL] [Abstract][Full Text] [Related]
5. Relationship between methylenetetrahydrofolate reductase gene polymorphisms and methotrexate drug metabolism and toxicity. Tan Y; Kong Q; Li X; Tang Y; Mai H; Zhen Z; Zhou D; Chen H Transl Pediatr; 2023 Jan; 12(1):31-45. PubMed ID: 36798930 [TBL] [Abstract][Full Text] [Related]
6. Methylenetetrahydrofolate reductase C677T and A1298C gene polymorphisms and therapy-related toxicity in children treated for acute lymphoblastic leukemia and non-Hodgkin lymphoma. Kantar M; Kosova B; Cetingul N; Gumus S; Toroslu E; Zafer N; Topcuoglu N; Aksoylar S; Cinar M; Tetik A; Eroglu Z Leuk Lymphoma; 2009 Jun; 50(6):912-7. PubMed ID: 19391036 [TBL] [Abstract][Full Text] [Related]
7. Impact of methylenetetrahydrofolate reductase (MTHFR) polymorphisms on methotrexate-induced toxicities in acute lymphoblastic leukemia: a meta-analysis. Yang L; Hu X; Xu L Tumour Biol; 2012 Oct; 33(5):1445-54. PubMed ID: 22528943 [TBL] [Abstract][Full Text] [Related]
8. The Frequency of A1298C and C677T Polymorphisms of the Methylentetrahydrofolate Gene in Turkish Patients with Rheumatoid Arthritis: Relationship with Methotrexate Toxicity. Taşbaş O; Borman P; Gürhan Karabulut H; Tükün A; Yorgancıoğlu R Open Rheumatol J; 2011; 5():30-5. PubMed ID: 22046205 [TBL] [Abstract][Full Text] [Related]
9. Influence of plasma methotrexate level and MTHFR genotype in Korean paediatric patients with acute lymphoblastic leukaemia. Chae H; Kim M; Choi SH; Kim SK; Lee JW; Chung NG; Cho B; Kim Y J Chemother; 2020 Sep; 32(5):251-259. PubMed ID: 32431230 [TBL] [Abstract][Full Text] [Related]
10. Study of the pharmacokinetic and pharmacogenetic contribution to the toxicity of high-dose methotrexate in children with acute lymphoblastic leukemia. El-Khodary NM; El-Haggar SM; Eid MA; Ebeid EN Med Oncol; 2012 Sep; 29(3):2053-62. PubMed ID: 21644011 [TBL] [Abstract][Full Text] [Related]
11. Effects of gene polymorphisms on delayed MTX clearance, toxicity, and metabolomic changes after HD-MTX treatment in children with acute lymphoblastic leukemia. Zhou Y; He H; Ding L; Wang T; Liu X; Zhang M; Zhang A; Fu J Eur J Pediatr; 2024 Feb; 183(2):581-590. PubMed ID: 37851084 [TBL] [Abstract][Full Text] [Related]
12. Interactions between genetic variants involved in the folate metabolic pathway and serum lipid, homocysteine levels on the risk of recurrent spontaneous abortion. Lin Z; Li Q; Sun Y; Huang J; Wang W; Fu J; Xu J; Zeng D Lipids Health Dis; 2019 Jun; 18(1):143. PubMed ID: 31200713 [TBL] [Abstract][Full Text] [Related]
13. 5,10-Methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms: genotype frequency and association with homocysteine and folate levels in middle-southern Italian adults. Zappacosta B; Graziano M; Persichilli S; Di Castelnuovo A; Mastroiacovo P; Iacoviello L Cell Biochem Funct; 2014 Jan; 32(1):1-4. PubMed ID: 24277487 [TBL] [Abstract][Full Text] [Related]
14. Methylene tetrahydrofolate reductase gene polymorphism in Egyptian children with acute lymphoblastic leukemia. Tantawy AA; El-Bostany EA; Adly AA; Abou El Asrar M; El-Ghouroury EA; Abdulghaffar EE Blood Coagul Fibrinolysis; 2010 Jan; 21(1):28-34. PubMed ID: 19923983 [TBL] [Abstract][Full Text] [Related]
15. Association between maternal Lu YJ; Li Q; Chen LX; Tian T; Kang J; Hao YX; Zhou JS; Wang YY; Yan LY; Li R; Chang L; Qiao J Hum Reprod Open; 2023; 2023(1):hoac055. PubMed ID: 36531663 [TBL] [Abstract][Full Text] [Related]
16. [Relationship between Yang FY; Xu LH; Wang J; Zhang YT; Lin SF; Wang KM; Zhou DH; Fang JP Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Auguest; 31(4):967-972. PubMed ID: 37551463 [TBL] [Abstract][Full Text] [Related]
17. Use of MTHFR C677T polymorphism and plasma pharmacokinetics to predict methotrexate toxicity in patients with acute lymphoblastic leukemia. Mahmoud LB; Mdhaffar M; Frikha R; Ghozzi H; Hakim A; Sahnoun Z; Elloumi M; Zeghal K Adv Clin Exp Med; 2018 Aug; 27(8):1061-1068. PubMed ID: 29911750 [TBL] [Abstract][Full Text] [Related]
18. Polymorphisms of SLC19A1 80 G>A, MTHFR 677 C>T, and Tandem TS Repeats Influence Pharmacokinetics, Acute Liver Toxicity, and Vomiting in Children With Acute Lymphoblastic Leukemia Treated With High Doses of Methotrexate. Cwiklinska M; Czogala M; Kwiecinska K; Madetko-Talowska A; Szafarz M; Pawinska K; Wieczorek A; Klekawka T; Rej M; Stepien K; Halubiec P; Lazarczyk A; Miklusiak K; Bik-Multanowski M; Balwierz W; Skoczen S Front Pediatr; 2020; 8():307. PubMed ID: 32612964 [No Abstract] [Full Text] [Related]
19. A systematic review and meta-analysis of MTHFR polymorphisms in methotrexate toxicity prediction in pediatric acute lymphoblastic leukemia. Lopez-Lopez E; Martin-Guerrero I; Ballesteros J; Garcia-Orad A Pharmacogenomics J; 2013 Dec; 13(6):498-506. PubMed ID: 23089671 [TBL] [Abstract][Full Text] [Related]
20. More severe toxicity of genetic polymorphisms on MTHFR activity in osteosarcoma patients treated with high-dose methotrexate. Xie L; Guo W; Yang Y; Ji T; Xu J Oncotarget; 2018 Feb; 9(14):11465-11476. PubMed ID: 29545912 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]